Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System
← catalyst calendarNCT01480440 · readout ≤ 134 d
Sponsored by Zimmer Biomet (industry) · ZBH — their whole pipeline →.
Phase
—
Status
Active, not recruiting
Study type
Observational
Enrollment
200estimated
Sites
5
Countries
United Kingdom, United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Jan 2011 | actual | When the study began enrolling |
| Primary completion | Dec 2026 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Dec 2026 | estimated | The whole study's end, after follow-up |
| First posted | 2011-11-28 | estimated | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-04-28 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Osteoarthritis
- Rheumatoid Arthritis
- Post-traumatic Arthritis
- Ununited Humeral Head Fracture
- Irreducible 3-and 4-part Proximal Humeral Fractures
- Avascular Necrosis
- Gross Rotator Cuff Deficiency
- Revision Total Shoulder Arthroplasty
Intervention
- Device: Trabecular Metal Reverse Shoulder System — also filed as TM Reverse Shoulder System, TM Reverse System, TM Reverse
Primary outcome
what the primary-completion date above is the date OFSurvivorship
measured 10 Years
Permalink · ZBH's whole pipeline · Catalyst calendar · Every registered study · What changed